Daewoong inks Autodelic deal to help international expansion
This article was originally published in Scrip
Executive Summary
After a fairly smooth launch for its combination drug Olostar in South Korea last year, Daewoong Pharmaceutical is now taking the product into global markets as part of its international expansion strategy.